VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

N. Gavalas; Marinos Tsiatas; Ourania Tsitsilonis; Ekaterini Politi; Kyriaki Ioannou; Apostolos C Ziogas; Alexandros Rodolakis; George Vlahos; Nikolaos Thomakos; Dimitrios Haidopoulos; Evangelos Terpos; A. Antsaklis; Meletios A Dimopoulos; Aristotle Bamias

doi:10.1038/bjc.2012.468

Related publications

Article2011

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals <i>via</i> VEGF receptor Type 2

Apostolos C Ziogas, Nikos G. Gavalas, Marinos Tsiatas, Ourania Tsitsilonis, Ekaterini Politi, Evangelos Terpos, Alexandros Rodolakis, George Vlahos, Nikolaos Thomakos, Dimitrios Haidopoulos, A. Antsaklis, Meletios A Dimopoulos, Aristotle Bamias

Article2011

The effect of VEGF on T cells from ovarian cancer patients and healthy individuals via VEGF receptor type 2.

Flora Zagouri, Apostolos C Ziogas, N. Gavalas, Marinos Tsiatas, Ourania Tsitsilonis, Ekaterini Politi, Chrysoula Liakou, Alexandra Karadimou, K. Arapini, Evangelos Terpos, Meletios A Dimopoulos, Aristotelis Bamias

Article2001

Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A.

Ananth Kadambi, Carla Mouta Carreira, Chae‐Ok Yun, Timothy P. Padera, D.E. Dolmans, Peter Carmeliet, Dai Fukumura, Rakesh K. Jain

Article2012

VEGF Receptor-2 (Flk-1) Overexpression in Mice Counteracts Focal Epileptic Seizures

Litsa Nikitidou, Irene Kanter‐Schlifke, Joke Dhondt, Peter Carmeliet, Diether Lambrechts, Mérab Kokaia

Article2021

Endothelial Insulin Receptors Promote VEGF-A Signaling via ERK1/2 and Sprouting Angiogenesis

Andrew MN Walker, Nele Warmke, Ben Mercer, Nicole T. Watt, Romana Mughal, Jessica Smith, Stacey Galloway, Natalie J Haywood, Taha Soomro, Kathryn J. Griffin, Stephen B. Wheatcroft, Nadira Yuldasheva, David J. Beech, Peter Carmeliet, Mark T. Kearney, Richard M. Cubbon